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Gastrointestinal cell proliferation and crypt fission
are separate but complementary means of
increasing tissue mass following infusion of
epidermal growth factor in rats
J Berlanga-Acosta, R J Playford, N Mandir, R A Goodlad
Abstract
Background and aims—Epidermal
growth factor (EGF) is a potent mitogen
for the gastrointestinal tract and also
influences the number of new crypts
formed by crypt fission. The time course
of these events and possible linkage be-
tween these two complementary mecha-
nisms is however poorly understood. We
therefore examined the temporal relation-
ship of proliferation and fission in rats
treated with EGF.
Methods—Osmotic minipumps were im-
planted subcutaneously into male Wistar
rats to infuse EGF continuously (60 µg/rat/
day) for periods of 1–14 days. Proliferation
and crypt branching were quantified fol-
lowing vincristine induced metaphase ar-
rest and morphometric assessment of
microdissected tissue.
Results—In the small intestine, EGF sig-
nificantly increased epithelial cell prolif-
eration and crypt and villus area after 24
hours of EGF, although maximal eVects
were only reached following six days of
infusion. EGF also resulted in an approxi-
mate 30% reduction in crypt fission in the
small bowel. In the colon, EGF caused a
twofold increase in epithelial cell prolif-
eration one day after infusion, from 15.3
(2.3) to 29.6 (3.5) metaphases per crypt
(p<0.01). Maximal eVects were seen in
rats receiving EGF for seven days. For all
time points, colonic crypt size increased
in response to EGF. The amount of
branching increased following one day of
infusion with EGF (from 15.3 (1.9) to 32.4
(5.5)%; p<0.001) but was significantly
lower (approximately 25% of control
values) following longer periods of infu-
sion. Crypt fission did not correlate with
crypt area.
Conclusion—EGF has profound eVects on
cell proliferation and also altered crypt
fission, with its actions on crypt fission
most pronounced in the colon where it
first increased and then decreased fission.
EGF can thus be a potent stimulus for
crypt fission during short term infusion
and may reduce the number of branched
crypts present in a resting or quiescent
stage. Growth factors can alter cell mass
by two separate but linked mechanisms,
namely altered cell production and crypt
fission.
(Gut 2001;48:803–807)
Keywords: epithelium; cell division; cell proliferation;
crypt fission; crypt branching; growth control;
epidermal growth factor; rat
The gastrointestinal tract is one of the most
rapidly proliferating organs in the body, second
only to the haematopoietic system. The
mechanisms underlying this process are how-
ever poorly understood. Although there has
been a great deal of research examining
changes in proliferation in response to growth
factors, it has been recently appreciated that an
additional mechanism involving the produc-
tion of new crypts is also important in mediat-
ing growth. New crypts are produced by a
process termed crypt fission.1 In this system, a
founder crypt divides into two or more daugh-
ter crypts, thereby allowing clonal expansion.
Crypt branching, which can be detected
morphometricaly, is the early visible stage of
the process. The controlling mechanisms
underlying crypt fission are however poorly
defined. We therefore performed a detailed
temporal study to examine the eVect of the
potent growth factor epidermal growth factor
(EGF)2 3 on crypt proliferation, compartment
size, and fission in the rat gut to determine
whether proliferation is inextricably linked to
crypt fission or is an independent but comple-
mentary process.
Methods
Recombinant EGF was produced by the
Center for Genetic Engineering and Biotech-
nology, Havana, Cuba, from expression of a
synthetic gene in Escherichia coli and was a
mixture of EGF1–51 and EGF1–52, was as biologi-
cal active as full length EGF1–53,
4 and was 99%
pure, as determined by high pressure liquid
chromatography.
Male 200 g Wistar rats were anaesthetised
with halothane and a small incision made
between the shoulders in the skin of the dorsal
neck. A pair of scissors was then used to make
a tunnel under the skin and a 2 ml, 14 day Alzet
osmotic minipump (model 2ml2; Charles
River UK Ltd, Kent, UK) was inserted and the
skin closed with a 4-0 wire suture. The pumps
were filled with EGF or saline, and had an out-
put of 5.25 µl/hour (126 µl/day) and thus a 0.48
µg/ml solution gave a daily output of 60 µg of
Abbreviations used in this paper: EGF, epidermal
growth factor; FAP, familial adenomatous polyposis;
ACF, aberrant crypt foci.
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EGF per rat per day. Four rats were killed after
1, 2, 3, 4, 5, 6, 8, 10, 12, and 14 days of
infusion. Control rats were also killed at the
start and end of the experiment (four on day 0
and six after 14 days of saline infusion).
At the end of the study, animals were killed
two hours after injection of 1 mg/kg of vincris-
tine (David Bull Laboratories, Harris Road,
Warwick). The wet weights of the various parts
of the gastrointestinal tract were recorded and
samples of the small intestine and colon
(defined by their percentage length) were fixed
in Carnoy’s fluid and stored in 70% (v/v) etha-
nol.
All animal procedures were approved by the
animal ethics committee of the Imperial
Cancer Research Fund and conformed to the
regulations of the Animals (Scientific Proce-
dures) Act 1986
Pieces of fixed tissue (from the proximal
small intestine and mid colon) were hydrated,
hydrolysed, stained with the Feulgen reaction,
and then transferred to 45% acetic acid and the
crypts teased apart under a dissecting micro-
scope (×40). Crypts were transferred to a glass
microscope slide, flattened gently beneath a
coverslip, and examined under a compound
microscope. The number of blocked meta-
phases per crypt was counted in 20 crypts per
animal,5 and 200 crypts were scored to
determine the crypt branching index.
Further subsamples of tissue were used to
determine crypt and villus area, which were
determined by tracing the crypts using a draw-
ing tube attached to the microscope.5 The scale
of these was set using a calibrated stage
micrometer slide. The drawings were then
scanned with a flatbed scanner connected to an
Apple Macintosh computer, and the area was
measured using the program Image (NIH
Public Domain).
STATISTICS
All results are presented as group mean
(SEM). Data were tested by analyses of
variance. Where statistical significance of
ANOVA was reached (p<0.05), individual
comparisons against (day 14) control values
were performed using Dunnet’s test, a method
equivalent to repeated measures analyses. In
addition, the non-parametric two sided runs
test was used to determine if the data were
non-random.
Results
WET WEIGHTS OF ORGANS
EGF caused progressive increases in the
weights of the stomach, small intestine, and
colon but caused only a transient increase in
the weight of the caecum (fig 1). At the end of
the 14 day infusion period, the weights of the
stomach and colon appeared to have reached
plateau levels although the small intestine did
not appear to have reached its maximal level
(fig 1). No eVect of EGF was seen on the
weight of the pancreas (data not shown).
Figure 1 The weights of the major gastrointestinal organs. Animals received 60 µg/rat/day epidermal growth factor
(EGF) at time 0. Significantly diVerent from day 14 saline infused controls (Dunnet’s test): *p<0.05,
**p<0.01,***p<0.001.
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MORPHOMETRIC ASSESSMENT OF THE SMALL
INTESTINE
The eVects of EGF on the morphometric
parameters of the proximal small intestine are
presented in fig 2. The number of arrested
metaphases per crypt was about twice that of
control animals after one day of EGF infusion
and values continued to increase until plateau
levels were reached by day 5, achieving values
which were about 150% greater than the start-
ing level. Crypt and villus areas were also twice
those of control animals following one day of
infusion of EGF but, in contrast with results
from metaphase assessment, there was little
further increases seen after infusion of EGF for
longer periods. Animals which had received
EGF for 14 days had 160% higher metaphase
counts per crypt, 100% greater crypt areas, and
180% greater villus areas (all p<0.01). The
actions of EGF on crypt branching were less
pronounced and showed a more gradual
decrease in crypt branching (p=0.023 by the
runs test).
MORPHOMETRIC ASSESSMENT OF THE COLON
The number of metaphase counts per crypt
increased by 93% after one day of EGF
infusion and continued to rise until reaching
plateau levels at about day 5 (fig 3). Animals
who had received EGF for 14 days had 280%
more metaphases per crypt compared with
animals not receiving EGF. Crypt area after
EGF showed a similar pattern to that seen for
Figure 2 EVect of epidermal growth factor (EGF) on
morphology and proliferation in the proximal bowel (10%
of the length of the small intestine). Animals received
60 µg/rat/day of EGF at time 0. Significantly diVerent
from day 14 saline infused controls: *p<0.05, **p<0.01,
and ***p<0.001. All of these parameters were significant
by analysis of variance (p<0.001) and the runs test
(p<0.001, 0.0026, and <0.001, respectively). The actions
of EGF on crypt branching were less pronounced, and
indicated a more gradual decrease in crypt branching;
nevertheless, analysis of variance was significant at
p<0.001 and the runs test also showed an eVect at
p=0.023.
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Figure 3 EVect of epidermal growth factor (EGF) on
morphology and proliferation in the mid colon (50% of the
length of the colon). Animals received 60 µg/rat/day of
EGF at time 0. Significantly diVerent from day 14 saline
infused controls: *p<0.05, **p<0.01, ***p<0.001.Mitotic
activity and crypt area were both significantly greater by
analysis of variance (p<0.001) and by the runs test
(p=0.03 and 0.047, respectively). Changes in crypt
branching were significant at p<0.001 by analysis of
variance and 0.0002 by the runs test.
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the number of metaphases. Animals that had
received EGF for one day had crypt areas of
about 145% of controls with values of about
160% being reached in animals receiving EGF
for 14 days (all p<0.01). Crypt branching
increased by about twofold in animals who
received EGF for one or two days; longer peri-
ods of infusion resulted in a marked decrease
(27% of that of saline infused) in the number of
branched crypts (fig 3).
Discussion
We have shown that EGF is a potent stimulus
for growth of the gastrointestinal tract, increas-
ing the wet weight and number of arrested
metaphases per crypt. The response of crypt
branching to EGF was more complicated,
showing peaks and troughs depending on the
time point studied. The proliferative response
to EGF was extremely rapid with most of the
increase in wet weight and villus area being
achieved within the first two days of infusion.
This again demonstrates that the gastro-
intestinal cell renewal system is very dynamic.
The actions of EGF on cell proliferation were
most pronounced in the colon6 7 with eVects on
crypt branching even more pronounced. Other
growth factors, such as keratinocyte growth
factor8 or glucagon-like peptide II,9 are more
potent in the proximal regions of the gastro-
intestinal tract.
Although a rise in proliferative rates in-
creases the number of cells within a crypt, it
does not facilitate replacement of lost crypts.
There is therefore currently much interest in
the mechanisms by which new crypts are
produced in adults. Crypt production consists
of a founder crypt becoming branched, which
subsequently separates into two or more
daughter crypts. This mechanism of new crypt
production is called crypt fission, with the
branching stage being the visible stage of the
process.10 Crypt fission is now thought to be of
major importance in intestinal development11
and is also increased following intestinal dam-
age and ulceration.12 13 Fission is also increased
in rats given chemical carcinogens3 and in mice
and humans with precancerous defects.14 It is
thus likely that crypt fission may provide a
mechanism for the duplication and fixation of
stem cell mutations and may thus contribute to
the spread of mutated crypts.15 16
The present study showed that EGF caused
a marked rise in the number of branched crypts
within the colon for the first two days of EGF
infusion, which was followed by a fall in the
number of branched crypts. While the reduc-
tion in crypt fission in the colon after one week
of infusion confirms our previous results,17 the
earlier increase in fission was not expected as
our previous study of a neonate with necrotis-
ing enteritis indicated that there was an initial
reduction in fission which preceded increased
proliferation.18 One possible explanation for
this is that EGF acted as a stimulant for crypt
fission/branching and then reduced the
number of “resting” branched crypts present in
the mucosa. Some of the branched crypts seen
under normal circumstances may represent a
resting stage, which acts as a reservoir for new
crypt production when a suitable stimulus
occurs. A large number of branched crypts are
seen in the mid colon of adult germ free rats
confirming that crypts can indeed rest in the
branched state.19 An alternative explanation is
that EGF acted as a stimulant for fission but
then exhibited tachyphylaxis (the rapidly de-
creasing response to an agent following admin-
istration of the initial dose). The data obtained
from the small intestine did not show this initial
increase in crypt branching. The small intes-
tine has a more rapid rate of proliferation than
the colon and there would appear to be major
diVerences in the crypt branching response in
the two regions of the bowel. The higher
incidence of crypts in fission in the colon com-
pared with the small intestine may be of great
significance; this diVerence is most pro-
nounced in the young (rat) and the greater fis-
sion incidences in the colon can lead to a more
rapid evolution of wholly mutated crypts in the
colon following mutagen administration.15 The
colon also may have fewer stem cells,20 which
may augment this. In addition, the results of
this study show that the colon is also more
responsive than the small intestine (in terms of
crypt fission), and although crypt fission is part
of the adaptive repertoire, increased fission can
also be a risk factor for carcinogenesis.
Crypt fission is likely to be of particular
importance for the elusive intestinal stem cell
as intestinal proliferation is a hierarchical pro-
cess in which a small number of cells near the
base of the crypt either have innately diVerent
characteristics or are in a unique “niche”.
These cells can give rise to all of the intestinal
cell types21 and are the functional intestinal
stem cells22 and as such are likely to be the main
target for carcinogenesis inasmuch as they do
not migrate whereas their daughter cells are
ephemeral.
There is currently uncertainty regarding the
relationship between proliferation and crypt
fission; Totafurno et al suggested that the two
process are linked, with proliferation increasing
crypt volume which in turn acts as the stimulus
for fission.10 23 The finding that colonic crypt
volume was high when the number of branched
crypts seen was low suggests that crypt volume
may not be the only factor involved.
It has been suggested that crypt reproduction
by fission may be a compensatory response to
crypt loss.17 Potten24 observed that apoptosis in
the proliferating zone of crypts is induced by
cytotoxic chemicals. If apoptosis occurs in the
stem cells, stem cell loss may lead to crypt dele-
tion. Moreover, the non-polypoid mucosa of
familial adenomatous polyposis (FAP), colon
cancer patients, and that of the murine homo-
logue of FAP, namely the multiple intestinal
neoplasia (Min) mouse,25 have elevated rates of
crypt fission.26 This lends weight to the hypoth-
esis that altered crypt fission may play an impor-
tant role in the process of carcinogenesis. The
development of aberrant crypt foci (ACF) in rats
treated with DMH may also be due to a fission
mechanism where indentations appear at the
base of a single ACF crypt, with subsequent for-
mation of multicryptal ACF,27 and the size of
ACF (multicrypt aberrant crypt multiplicity)
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has been shown to be a better predictor of sub-
sequent tumorigenicity than the number of
ACF.28 29 Crypt fission may thus be the means by
which mutated clones spread through tissues
before becoming overtly invasive. While there is
substantial evidence in favour of independent
origins of each tumour from a unique mutated
clone, there are instances where such clones
expand and remain cohesive, often involving a
large area of tissue.16
In conclusion, we have shown that crypt fis-
sion as well as cell proliferation can play a
major role in colonic adaptation, so that the gut
can respond to growth signals in a variety of
ways. The implications of this have yet to be
determined but some of the findings of
increased fission rates in carcinogen treated
animals and humans with FAP would suggest
that increased crypt fission, perhaps related to
decreased cell-cell adhesion, is a major factor in
the progression of cancer.
We thank the Royal Society for financial assistance for JB and
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